Press release
United States Membranous Nephropathy Market Forecast 2024-2031: Rising Prevalence of Kidney Disorders, Advances in Biologics, and Growth of Personalized Therapies | F. Hoffman La Roche, SynAct Pharma, Roxane Laboratories, Inc.
Membranous Nephropathy Market
The membranous nephropathy market focuses on treatments for this rare kidney disorder characterized by thickening of the glomerular basement membrane. Therapeutics include immunosuppressive agents, corticosteroids, and emerging biologics targeting disease-specific pathways. Market growth is driven by rising prevalence of chronic kidney diseases and increasing diagnosis rates. Personalized medicine and biomarker-based therapies are shaping treatment approaches. Research is focused on targeted therapies to improve efficacy and reduce side effects. Awareness programs and advanced diagnostics enhance early detection and patient management.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Membranous Nephropathy Market Landscape:- https://datamintelligence.com/download-sample/membranous-nephropathy-market?rk
☛ Membranous Nephropathy Market Recent Developments 2025:
United States: Recent Industry Developments
✅ In August 2025, Novartis launched novel therapeutics for membranous nephropathy, targeting autoantibody-mediated disease.
✅ In July 2025, Roche expanded its kidney disease treatment portfolio, supporting personalized therapy for patients.
✅ In June 2025, Bristol-Myers Squibb partnered with hospitals to deploy advanced treatment protocols, improving outcomes in membranous nephropathy.
Europe: Recent Industry Developments
✅ In July 2025, Novartis Europe introduced next-generation drugs for membranous nephropathy.
✅ In June 2025, Roche Europe expanded clinical programs for kidney disorders.
✅ In May 2025, BMS Europe partnered with EU hospitals to implement advanced nephropathy treatment strategies.
Japan: Recent Industry Developments
✅ In July 2025, Takeda Pharmaceutical launched therapies for membranous nephropathy in Japan.
✅ In June 2025, Astellas Pharma expanded its kidney disease treatment offerings.
✅ In May 2025, Chugai Pharmaceutical partnered with hospitals to deploy advanced treatment solutions, enhancing patient care.
☛ Membranous Nephropathy Market Trends:
Membranous nephropathy (MN) is a rare kidney disorder causing nephrotic syndrome, treated with immunosuppressants, biologics, and supportive therapies. Market growth is driven by early diagnosis, increasing prevalence of chronic kidney diseases, and therapeutic innovations.
Trends include targeted therapies, biologics, and personalized treatment regimens. North America and Europe dominate due to advanced diagnostics and healthcare access, while Asia-Pacific is growing with rising CKD awareness. Challenges include high treatment costs and limited awareness in emerging regions.
☛ Membranous Nephropathy Market Competitve Landscape:
F. Hoffman La Roche, SynAct Pharma, Roxane Laboratories, Inc, Dr. Reddy's Laboratories Ltd., Genentech, Inc., Novartis AG, Anant Pharmaceuticals Pvt. Ltd, Merck KGaA, Panacea Biotec.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/membranous-nephropathy-market
☛ Segment Covered in the Membranous Nephropathy Market:
By Type: Primary Membranous Nephropathy, and Secondary Membranous Nephropathy.
By Drugs: Alkylating Agents, Immunosuppressive Agents, Calcineurin Inhibitors, Adrenocorticotropic Hormone (ACTH) Analogs, and Rituximab.
By Route of Administration: Oral, Intravenous, and Others.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Membranous Nephropathy Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=membranous-nephropathy-market
☛ Regional Analysis for Membranous Nephropathy Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Membranous Nephropathy Market Forecast 2024-2031: Rising Prevalence of Kidney Disorders, Advances in Biologics, and Growth of Personalized Therapies | F. Hoffman La Roche, SynAct Pharma, Roxane Laboratories, Inc. here
News-ID: 4207473 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Frozen Fruits Market Surges Toward US$6.54 Billion by 2030 - Asia-Pacific Leads …
According to DataM Intelligence, the global frozen fruits market size was valued at US$3,957.4 million in 2022 and is forecasted to reach US$6,549.4 million by 2030, growing at a CAGR of 6.5% from 2024 to 2031. This steady growth is propelled by rising health consciousness among consumers, increasing demand for convenient and nutritious food options, expanding food processing and service sectors, growing preference for organic and plant-based products, surging popularity…
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates …
According to DataM Intelligence, the global feed testing market size was valued at US$3.50 billion in 2024 and is forecasted to reach US$5.70 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031). This steady growth is propelled by stringent regulatory standards for animal feed safety, rising demand for high-quality meat and dairy products, increasing livestock production, growing pet food safety concerns, and expanding focus on…
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Custo …
According to DataM Intelligence, the global sugar decorations and inclusions market size was valued at US$2.15 billion in 2023 and is forecasted to reach US$3.45 billion by 2030, growing at a CAGR of 5.80% from 2023 to 2030. This steady growth is propelled by rising demand for personalized baked goods, expanding bakery and confectionery sectors, increasing consumer preference for visually appealing desserts, growth in organized retail for convenience foods, and…
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and …
Global Aluminum Extrusion Market reached US$ 78.7 billion in 2022 and is expected to reach US$ 117.8 billion by 2030, growing with a CAGR of 5.7% during the forecast period 2025-2031.
According to DataM Intelligence has published a new research report on "Aluminium Extrusion Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and…
More Releases for Membranous
Membranous Nephropathy Market Drug Innovations, Diagnostic Improvements & Strate …
The Membranous Nephropathy Market is gaining significant attention as chronic kidney disease (CKD) cases rise and advanced immunology research uncovers new treatment pathways. With improved diagnostics, targeted biologics, and better understanding of autoimmune triggers, the market is set for strong growth through 2034.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/52007
Understanding the Membranous Nephropathy Market
Membranous nephropathy (MN) is a chronic kidney disorder characterized by thickening of the glomerular basement…
Membranous Nephropathy Market Positioned for Accelerated Development Through 203 …
DelveInsight's "Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Membranous Nephropathy, historical and forecasted epidemiology as well as the Membranous Nephropathy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Membranous Nephropathy market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Membranous Nephropathy Market Forecast
https://www.delveinsight.com/sample-request/membranous-nephropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Idiopathic Membranous Nephropathy Market Size And Global Industry Forecast 2034
Introduction
The Idiopathic Membranous Nephropathy (IMN) Market is experiencing steady growth as medical research advances understanding of this rare, immune-mediated kidney disorder. IMN, a leading cause of nephrotic syndrome in adults, is characterized by immune complex deposits on the glomerular basement membrane, leading to proteinuria and potential progression to kidney failure. Rising adoption of biomarker-driven diagnostics, targeted therapies, and increasing awareness in nephrology are expected to expand treatment adoption globally.
Download Full…
Membranous Nephropathy Market Forecasted for Consistent CAGR through 2024-2031
Membranous Nephropathy Market analysis, according to DataM Intelligence, offers more than just an overview; it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.
Will the Membranous Nephropathy market emerge as the sector's next great…
Membranous Nephropathy Market Forecast period 2022-2029.
The report is designed to provide a holistic view of the Membranous Nephropathy Market It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South…
Membranous Nephropathy Market Report Covers Future Trends with Research 2023-203 …
Market Research, INC. has recently published a report on Membranous Nephropathy market which is an essential tool for businesses to gather critical insights about their target markets, competitors, and industry trends. With the increasing complexity of the global business environment, companies need accurate and up-to-date information to make informed decisions and stay ahead of the competition. That's why we are excited to announce the release of our latest market research…
